Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T. Scott, David Vetrie|Cancer Discovery|2016Cited by 132
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML diseaseMary T. Scott, David Vetrie|Nature Communications|2024Cited by 15